Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
  1. 4 Open-market sale President and CEO sold 55,172 shares at an average $4.19 ($231,339)
  2. 4 Open-market sale SVP, CFO & Treasurer sold 14,700 shares at an average $4.31 ($63,393)
  3. 4 Open-market sale SVP, Business Development sold 17,411 shares at an average $4.21 ($73,379)
  4. 4 Grant or award SVP & General Counsel acquired 125,000 shares (grant or award)
  5. 4 Grant or award SVP, Chief Marketing Officer acquired 32,700 shares (grant or award)
  6. 4 Grant or award SVP, CFO & Treasurer acquired 125,000 shares (grant or award)
  7. 4 Grant or award President and CEO acquired 450,000 shares (grant or award)
  8. 4 Grant or award SVP, Business Development acquired 125,000 shares (grant or award)
  9. 4 Open-market sale SVP, Chief Marketing Officer sold 3,724 shares at $5.84 ($21,748)
  10. 4 Open-market sale Director sold 6,500 shares at $6.05 ($39,349)
  11. 4 Open-market sale SVP, CFO & Treasurer sold 2,212 shares at an average $6.30 ($13,945)
  12. 4 Open-market sale SVP, CFO & Treasurer sold 16,000 shares at $6.29 ($100,710)
  13. 4 Open-market sale SVP & General Counsel sold 14,600 shares at $6.56 ($95,754)
  14. 4 Grant or award Director acquired 17,307 shares (grant or award)
  15. 4 Grant or award Director acquired 17,307 shares (grant or award)
  16. 4 Grant or award Director acquired 17,307 shares (grant or award)
  17. 4 Grant or award Director acquired 17,307 shares (grant or award)
  18. 4 Grant or award Director acquired 17,307 shares (grant or award)
  19. 4 Grant or award Director acquired 26,408 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 4 of 29 · 579 filings